Search

everythinglearnresearchcommunity

for

Search:↓

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Polycystic Ovary Syndrome is common but often undiagnosed, and early treatment is important to prevent health problems.

A significant number of Nigerian women struggling with infertility have Polycystic Ovary Syndrome, with the exact percentage varying based on the diagnostic criteria used.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Manage PCOS in primary care with weight loss, psychological support, medication, and monitoring for health risks.

Anorexia Nervosa and Bulimia Nervosa are complex eating disorders with increasing incidence among young females, significant morbidity, and varying mortality rates, requiring more research for better treatment.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Skin problems like excessive hair growth, acne, and dark skin patches can be signs of Polycystic Ovarian Disease, which may also be linked to family history and a risk for diabetes.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.

Women with acne after adolescence are more likely to have PCOS and should be checked for it.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

The rat model showed early perimenopause with regular cycles and low hormones, and late perimenopause with irregular cycles and higher hormone levels.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

Low estrogen compared to androgen may cause female hair loss.